Literature DB >> 28406012

Immunomodulatory Magnetic Microspheres for Augmenting Tumor-Specific Infiltration of Natural Killer (NK) Cells.

Wooram Park1, Andrew C Gordon1, Soojeong Cho1, Xiaoke Huang1, Kathleen R Harris1, Andrew C Larson1,2, Dong-Hyun Kim1,2.   

Abstract

The purpose of this research is to develop magnetic resonance imaging (MRI) visible immunomodulatory microspheres (IMM-MS) for efficient image guided cancer immunotherapy. IMM-MS composed of recombinant interferon gamma (IFN-γ), iron oxide nanocubes (IONC), and biodegradable poly(lactide-co-glycolide) (PLGA) were successfully prepared via a double-emulsion method. The prepared IMM-MS exhibited a sustained IFN-γ release and highly sensitive MR T2 contrast effects. Finally, in an orthotopic liver tumor VX2 rabbit model, successful hepatic intra-arterial (IA) transcatheter delivery of IMM-MS to liver tumors was confirmed with MR images. The deposition of IMM-MS significantly increased NK-cell infiltration into the liver tumor site.

Entities:  

Keywords:  and image-guided therapy; cancer immunotherapy; interferon-gamma (IFN-γ); microspheres; natural killer (NK) cells infiltration

Mesh:

Substances:

Year:  2017        PMID: 28406012      PMCID: PMC5719880          DOI: 10.1021/acsami.7b02258

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  27 in total

1.  Acidic pH-Triggered Drug-Eluting Nanocomposites for Magnetic Resonance Imaging-Monitored Intra-arterial Drug Delivery to Hepatocellular Carcinoma.

Authors:  Wooram Park; Jeane Chen; Soojeong Cho; Sin-Jung Park; Andrew C Larson; Kun Na; Dong-Hyun Kim
Journal:  ACS Appl Mater Interfaces       Date:  2016-05-16       Impact factor: 9.229

2.  CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo.

Authors:  Erik Wennerberg; Veronika Kremer; Richard Childs; Andreas Lundqvist
Journal:  Cancer Immunol Immunother       Date:  2014-10-26       Impact factor: 6.968

Review 3.  Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.

Authors:  J K Chan; V C Sin; K F Wong; C S Ng; W Y Tsang; C H Chan; M M Cheung; W H Lau
Journal:  Blood       Date:  1997-06-15       Impact factor: 22.113

4.  Ultra-large-scale syntheses of monodisperse nanocrystals.

Authors:  Jongnam Park; Kwangjin An; Yosun Hwang; Je-Geun Park; Han-Jin Noh; Jae-Young Kim; Jae-Hoon Park; Nong-Moon Hwang; Taeghwan Hyeon
Journal:  Nat Mater       Date:  2004-11-28       Impact factor: 43.841

5.  IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organs.

Authors:  Ori Wald; Ido D Weiss; Hanna Wald; Hadas Shoham; Yochay Bar-Shavit; Katia Beider; Eithan Galun; Lola Weiss; Liat Flaishon; Idit Shachar; Arnon Nagler; Bao Lu; Craig Gerard; Ji-Liang Gao; Eyal Mishani; Joshua Farber; Amnon Peled
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

6.  Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression.

Authors:  Liang Shi; Hui Lin; Gonghui Li; Ren-An Jin; Junjie Xu; Yin Sun; Wen-Lung Ma; Shuyuan Yeh; Xiujun Cai; Chawnshang Chang
Journal:  Mol Cancer Ther       Date:  2016-03-03       Impact factor: 6.261

Review 7.  Targeting natural killer cells in cancer immunotherapy.

Authors:  Camille Guillerey; Nicholas D Huntington; Mark J Smyth
Journal:  Nat Immunol       Date:  2016-08-19       Impact factor: 25.606

8.  Quantitative functional MRI in a clinical orthotopic model of pancreatic cancer in immunocompetent Lewis rats.

Authors:  Zhuoli Zhang; Linfeng Zheng; Weiguo Li; Andrew C Gordon; Yi Huan; Junjie Shangguan; Daniel Procissi; David J Bentrem; Andrew C Larson
Journal:  Am J Transl Res       Date:  2015-09-15       Impact factor: 4.060

9.  Efficacy of transcatheter arterial chemoembolization combined with cytokine-induced killer cell therapy on hepatocellular carcinoma: a comparative study.

Authors:  Ming-Zhi Hao; Hai-Lan Lin; Qiang Chen; Yun-Bin Ye; Qi-Zhong Chen; Ming-Shui Chen
Journal:  Chin J Cancer       Date:  2010-02

10.  Percutaneous ultrasound guided implantation of VX2 for creation of a rabbit hepatic tumor model.

Authors:  Sarah B White; Jeane Chen; Andrew C Gordon; Kathleen R Harris; Jodi R Nicolai; Derek L West; Andrew C Larson
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

View more
  16 in total

1.  Development and Validation of Sorafenib-eluting Microspheres to Enhance Therapeutic Efficacy of Transcatheter Arterial Chemoembolization in a Rat Model of Hepatocellular Carcinoma.

Authors:  Wooram Park; Soojeong Cho; Jingran Ji; Robert J Lewandowski; Andrew C Larson; Dong-Hyun Kim
Journal:  Radiol Imaging Cancer       Date:  2021-01-08

2.  Advanced smart-photosensitizers for more effective cancer treatment.

Authors:  Wooram Park; Soojeong Cho; Jieun Han; Heejun Shin; Kun Na; Byeongdu Lee; Dong-Hyun Kim
Journal:  Biomater Sci       Date:  2017-12-19       Impact factor: 6.843

3.  Comparison of anesthesia and tumor implantation methods for establishing rabbit VX2 hepatocarcinoma.

Authors:  Jiayi Liu; Yanhui Li; Jie Zhang; Yeyu Cai; Quanliang Shang; Cong Ma; Dujun Bian; Zhu Chen; Enhua Xiao
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

4.  Multifunctional Nanocarriers-Mediated Synergistic Combination of Immune Checkpoint Inhibitor Cancer Immunotherapy and Interventional Oncology Therapy.

Authors:  Bongseo Choi; Dong-Hyun Kim
Journal:  Adv Nanobiomed Res       Date:  2021-08-02

5.  PLGA Microspheres Containing Hydrophobically Modified Magnesium Hydroxide Particles for Acid Neutralization-Mediated Anti-Inflammation.

Authors:  Joon-Kyu Kim; Eun-Jin Go; Kyoung-Won Ko; Hyeon-Ji Oh; Jieun Han; Dong Keun Han; Wooram Park
Journal:  Tissue Eng Regen Med       Date:  2021-04-20       Impact factor: 4.169

Review 6.  Advanced biomaterials for cancer immunotherapy.

Authors:  Fan Yang; Kun Shi; Yan-Peng Jia; Ying Hao; Jin-Rong Peng; Zhi-Yong Qian
Journal:  Acta Pharmacol Sin       Date:  2020-03-02       Impact factor: 6.150

Review 7.  New opportunities for nanoparticles in cancer immunotherapy.

Authors:  Wooram Park; Young-Jae Heo; Dong Keun Han
Journal:  Biomater Res       Date:  2018-09-26

Review 8.  Optimizing NK Cell-Based Immunotherapy in Myeloid Leukemia: Abrogating an Immunosuppressive Microenvironment.

Authors:  Natasha Mupeta Kaweme; Fuling Zhou
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

Review 9.  Overview of Strategies to Improve Therapy against Tumors Using Natural Killer Cell.

Authors:  Chaopin Yang; Yue Li; Yaozhang Yang; Zhiyi Chen
Journal:  J Immunol Res       Date:  2020-01-21       Impact factor: 4.818

10.  Image-Guided Cancer Nanomedicine.

Authors:  Dong-Hyun Kim
Journal:  J Imaging       Date:  2018-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.